FinanceBenchmark offloads UK vaccine facility amid COVID-19 responseThe sale comes as the UK government is scaling up infrastructure to support the manufacturing of human vaccines and therapeutics in the wake of COVID-19.Trond Williksen, CEO of Benchmark, the aquaculture genetics firm.Photo: Anders FurusetDemi Korban